Research Analysts’ Weekly Ratings Changes for Bruker (BRKR)

Several brokerages have updated their recommendations and price targets on shares of Bruker (NASDAQ: BRKR) in the last few weeks:

• 7/8/2026 – Bruker had its price target raised by Citigroup Inc. from $44.00 to $60.00. They now have a “neutral” rating on the stock.
• 7/7/2026 – Bruker had its price target raised by Leerink Partners from $60.00 to $70.00. They now have an “outperform” rating on the stock.
• 6/29/2026 – Bruker had its price target raised by Guggenheim from $50.00 to $70.00. They now have a “buy” rating on the stock.
• 6/24/2026 – Bruker was given a new $60.00 price target by UBS Group AG.
• 6/24/2026 – Bruker had its price target raised by Barclays PLC from $53.00 to $60.00. They now have an “overweight” rating on the stock.
• 6/8/2026 – Bruker had its price target raised by JPMorgan Chase & Co. from $55.00 to $65.00. They now have an “overweight” rating on the stock.
• 6/3/2026 – Bruker was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 6/1/2026 – Bruker is now covered by Wolfe Research. They set a “peer perform” rating on the stock.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Monday, June 22nd were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Monday, June 22nd. Bruker’s dividend payout ratio (DPR) is -83.33%.

Insiders Place Their Bets

In other Bruker news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $39.90, for a total value of $79,800.00. Following the transaction, the vice president directly owned 128,443 shares in the company, valued at $5,124,875.70. The trade was a 1.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 27.20% of the company’s stock.

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.